In this episode, Dr. Hind Rafei dives into the cutting-edge world of CAR-NK cell therapy and its potential to revolutionize cancer treatment. Unlike their T-cell counterparts, CAR-NK cells promise enhanced safety and innate tumor-killing ability. But what if their power could be dialed up even further?
Dr. Rafei discusses her team's groundbreaking discovery ... Show More
Sep 5
Breaking the Stigma: The Fight for LGBTQ+ Health Equity in Lebanon | The LebMASH Story
What happens when stigma and discrimination become barriers to healthcare? In this powerful episode of The Lebanese Physicians Podcast, Dr. Sarah Abboud, Dr. Zavi Lakissian, and Dr. Claude Chidiac share the story of LebMASH (Lebanese Medical Association for Sexual Health) and its ... Show More
50m 14s
Aug 30
From Lebanon to the World: ILMA USA & the Power of the Medical Diaspora
How can Lebanon’s “brain drain” become a powerful global brain network? In this special episode of The Lebanese Physicians Podcast, I discuss with leaders from ILMA USA the growing Lebanese medical diaspora, mentorship and research opportunities, supporting the next generation of ... Show More
36m 8s
Aug 23
The Future of AI in Healthcare: What Every Physician Needs to Know | Carter Abdullah
How will AI transform the way physicians practice medicine? In this episode of The Lebanese Physicians Podcast, I speak with Carter Abdullah, an AI engineer and developer of Brev.dev, about the rapidly evolving role of artificial intelligence in healthcare. We discuss how AI can ... Show More
36m 10s
Sep 2020
Immunotherapy: Transforming How Cancers Are Treated
In this episode, Dr. Diane Reidy-Lagunes talks to medical oncologist and scientist Dr. Jedd Wolchok and cancer survivor Grace Dunn. Together, they help decode the emerging new defense against cancer: immunology. For more information or to ask a question, please visit MSKCC.org/po ... Show More
23m 44s
Nov 2024
CAR T Cells and T-Cell Therapies for Cancer
<p>CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott ... Show More
18m 22s
Aug 2024
CAR T-cell Therapy in AML: State of the Art
Tune in to our podcast for an in-depth discussion on immunotherapeutic strategies for Acute Myeloid Leukemia (AML). In this episode, we feature Dr Sarah Tettamanti, a senior scientist at the Fondazione Tettamanti Research Centre in Italy, who shares her expertise on CAR T-cell th ... Show More
15m 1s